在II型子宫内膜癌中人工智能驱动的进展:全球趋势和非洲背景
Thulo Molefi1,2,3, Lloyd Mabonga2, Rodney Hull2
1Discipline of Obstetrics and Gynaecology, School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.
Frontiers in oncology
|July 24, 2025
概括
人工智能 (AI) 为治疗II型侵袭性子宫内膜癌 (ECs) 提供了新的希望,特别是在非洲. 人工智能集成可以改善诊断,个性化治疗,减少医疗保健差异,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 人工智能的人工智能
- 医疗信息学 医疗信息学
背景情况:
- 二型子宫内膜癌 (ECs) 具有攻击性,占大多数EC死亡人数,并且经常被诊断为晚期,特别是在非洲.
- 目前针对II型EC的治疗方法不足,缺乏向疗法,并且经常反映出不那么积极的I型EC.
- 非洲越来越多的发病率和待遇差异需要对II型EC管理采取创新方法.
研究的目的:
- 审查人工智能 (AI) 在II型EC的诊断,治疗和预后中的整合.
- 探索AI在解决非洲II型EC日益增长的发病率和医疗保健差异方面的潜力.
- 突出创新的AI项目,包括对土著知识的整合,用于II型EC护理.
主要方法:
- 对瘤学中人工智能应用的文献综述,特别是针对II型ECs.
- 对II型EC的AI驱动的诊断工具和治疗策略的分析.
- 对正在进行的项目进行审查,重点是针对II型EC的非洲医疗保健环境中的AI.
主要成果:
- 人工智能驱动的工具显示出提高II型EC的诊断和预后的前景.
- 量身定制的AI驱动的治疗选择为II型EC患者提供了向治疗的潜力.
- 非洲的创新人工智能项目显示出减少医疗保健差异和改善结果的潜力.
结论:
- 人工智能技术具有改造性的潜力,可以改善II型EC诊断,治疗和管理,特别是在非洲.
- 将AI整合到II型EC护理连续体中可以帮助克服医疗保健挑战并减少差异.
- 人工智能驱动的疗法,结合土著知识,可以为II型EC带来个性化和非洲中心的医疗保健解决方案.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K